Rafferty Asset Management, LLC Ginkgo Bioworks Holdings, Inc. Transaction History

Rafferty Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$1.06 - $1.67 $50,191 - $79,074	-47,350 Reduced 10.5%	403,622 $468,000
Q4 2023 Feb 13, 2024	BUY	$1.26 - $1.79 $74,696 - $106,116	59,283 Added 15.14%	450,972 $762,000
Q3 2023 Nov 13, 2023	SELL	$1.61 - $2.54 $7,740 - $12,212	-4,808 Reduced 1.21%	391,689 $708,000
Q2 2023 Aug 11, 2023	BUY	$1.14 - $1.95 $10,208 - $17,462	8,955 Added 2.31%	396,497 $737,000
Q1 2023 May 11, 2023	SELL	$1.2 - $2.19 $4,224 - $7,708	-3,520 Reduced 0.9%	387,542 $515,000
Q4 2022 Feb 13, 2023	BUY	$1.63 - $3.52 $61,129 - $132,010	37,503 Added 10.61%	391,062 $660,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $242,292 - $1.24 Million	331,907 Added 1532.92%	353,559 $1.1 Million
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $47,634 - $90,938	21,652 New	21,652 $52,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.